It's a good first step. I'm not dismissing the mouse model, it's well validated and informative. But the real and massive bang for buck would come from showing a reduction in infection rate or viral load in people, until then it's still just in the "this is nice and promising but where's the RCT" category.
Ann: VIRALEZE Protects Against SARS-CoV-2 in Challenge Model, page-7
-
- There are more pages in this discussion • 70 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
